4.9/5
( 797+ reviews)
Features SGLT2 & GLP-1 in Diabetes
This tool can be used for peer-to-peer, physician-to-patient, and physician-to-caregiver discussions, allowing you to virtually explore two important drug classes used in type 2 diabetes: SGLT2 inhibitors and GLP-1 receptor agonists.
The benefits of these agents are carefully described, matched to a visually engaging depiction of their glucose-lowering mechanisms and their effects on different organ systems.
Secure & Private
Your data is protected with industry-leading security protocols.
24/7 Support
Our dedicated support team is always ready to help you.
Personalization
Customize the app to match your preferences and workflow.
Screenshots
See the SGLT2 & GLP-1 in Diabetes in Action
Get the App Today
Download on Google Play
Available for Android 8.0 and above